SEC Form 4 · accession 0001127602-18-002646
HAEMONETICS CORP · HAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ellen M Zane
Director
Period of report
Jan 24, 2018
Accepted (ET)
Jan 26, 2018 · 4:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000313143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 24, 2018 | A | 1,301 | $65.86 | A | 1,301 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Restricted Stock Unit grant which vests 100% on the first anniversary of the grant date. The grant was made under the 2005 Long Term Incentive Compensation Plan.